IP Verse

Wuesthoff & Wuesthoff competitive analysis

Latest oppositions filed by Wuesthoff & Wuesthoff

Explore patent oppositions filed by Wuesthoff & Wuesthoff against competitors, revealing strategic technology disputes and market positioning.

Last updated on: May 21, 2026
Patent NumberTitleApplicantOpposition Date
EP4121007
High Concentration Anti-Ass Protofibril Antibody Formulations And Methods Of Use ThereofEISAI R&D MANAGEMENTApr 1, 2026
EP3858859
Method Of Treating Cancer Using Immune Checkpoint Inhibitor; Antibody That Binds To Programmed Death-1 Receptor (Pd-1) Or Programmed Death Ligand 1 (Pd-L1)BRISTOL MYERS SQUIBBMar 12, 2026
EP4076569
Cassette Design And Systems And Methods ThereofJOHNSON & JOHNSON SURGICAL VISIONFeb 5, 2026
EP3539540
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 16, 2025
EP3171860
Solid Oral Formulation Of FenretinideLAURENT PHARMACEUTICALSSep 9, 2025
EP3509637
Methods Of Using A Bispecific Antibody That Recognizes Coagulation Factor Ix And/Or Activated Coagulation Factor Ix And Coagulation Factor X And/Or Activated Coagulation Factor XCHUGAI SEIYAKU KABUSHIKI KAISHAAug 25, 2025
EP3689365
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISKAug 6, 2025
EP4321157
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025
EP3638243
Methods For Treating Myeloproliferative Neoplasm-Associated Myelofibrosis And AnemiaCELGENEMay 5, 2025
EP3490582
Methods And Compositions For Treating MyelofibrosisACCELERON PHARMAMar 10, 2025

Latest PTAB cases involving Wuesthoff & Wuesthoff

Discover the latest PTAB cases involving Wuesthoff & Wuesthoff, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Wuesthoff & Wuesthoff with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: May 21, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
WUESTHOFF & WUESTHOFF PATENTANWALTE PARTG MBB35 - - -
CELGENE - 68 - 11
NOVARTIS6441 - 21
REGENERON PHARMACEUTICALS3894932